TABLE 2.
The effects of INSL-4 on the viability of WISH and JAR cells.a
| Treatment | WISH | JAR |
|---|---|---|
| IGF-II (30ng/ml) | 154.4 ±23.9b | 104.1 ± 6.9 |
| INSL-4 (3ng/ml) | 90.3 ± 14.6 | 94.1 ± 6.2b |
| INSL-4 (10ng/ml) | 91.6 ± 14.9 | 88.4 ± 9.5b |
| INSL-4 (30ng/ml) | 81.3 ± 14.2b | 96.6 ± 13.9 |
values as % of control ± SD, n=4 for both WISH and JAR
p<0.05 compared to control